Since the onset of the Covid-19 pandemic, our society has had to adapt to unprecedented restrictions and limitations. During this trying time, it has been difficult to find points of optimism. The rapid development of vaccine candidates utilizing varied techniques remains encouraging. However, while expeditious availability of effective vaccines is a laudable goal, the physician-led organizations presenting this statement stress the need for assurances of safety, efficacy, and a full commitment to uncompromised ethical development.
There are many vaccine candidates under development with newer technologies that have received much attention. These include the use of viral genetic material (mRNA and DNA), the synthesis of viral protein in a laboratory, and the incorporation of coronavirus genetic information into another harmless carrier virus that is then injected. The use of these techniques has produced very few effective and approved vaccines for any viral infection thus far. Recent reports of the effectiveness of the Pfizer/BioNTech and Moderna Covid-19 vaccines, which are both mRNA vaccines, are encouraging. Although it is true that the animal-phase testing for these vaccines used abortion-derived fetal cells, commendably, it does not appear that production methods utilized such cells.
Considerable attention is also being directed at the use of adenoviruses, a group of common respiratory viruses. After disabling the virus and inserting coronavirus genetic material, the resulting product could be used for vaccination. However, as with other newer vaccines, the adenovirus delivery protocol has not produced a licensed vaccine despite many years of attempts. Of further concern is the standard use of abortion-derived fetal cell lines to produce these vaccines by companies such as AstraZeneca and Johnson & Johnson. Sadly, many other current vaccine candidates being developed also utilize cell lines derived from aborted babies for their production.
Fortunately, there are alternatives that do not violate this basic ethical and moral standard. Over the past decades, more than fifty viral vaccines have been approved using an attenuated or inactivated vaccine. Many of these vaccines have not utilized abortion-derived fetal cell lines for their production. The virus is grown in the laboratory and harvested, then weakened or inactivated to serve as a safe vaccine. In addition, other means of manufacturing with fully ethical protocols are used, including the John Paul II Medical Research Institute’s use of umbilical cord and adult stem cells. These and other ethical approaches provide encouragement for the future, where no vaccine will violate the dignity of human life in their production….
The organizations supporting this physicians statement:
American Association of Pro-Life Obstetricians and Gynecologists – aaplog.org
American College of Pediatricians – acpeds.org
Catholic Medical Associations – cathmed.org
Christian Medical and Dental Association – cmda.org
The above comes from a Dec. 2 email sent by American Association of Pro-Life Obstetricians and Gynecologists.
Tangu kuanza kwa janga la COVID-19, jamii yetu imelazimika kukabiliana na vizuizi na mapungufu yasiyo na kifani. Katika wakati huu mgumu, imekuwa vigumu kupata mambo yenye kufurahisha. Maendeleo ya haraka ya wagombea wa chanjo wakitumia mbinu mbalimbali bado yanatia moyo. Hata hivyo, wakati upatikanaji wa haraka wa chanjo zenye ufanisi ni lengo la sifa, mashirika yanayoongozwa na madaktari yanayotoa taarifa hii yanasisitiza hitaji la uhakikisho wa usalama, ufanisi, na kujitolea kamili kwa maendeleo ya maadili yasiyo na makubaliano. Kuna wagombea wengi wa chanjo wanaotengenezwa na teknolojia mpya ambazo zimepokea umakini mwingi. Hizi ni pamoja na matumizi ya virusi vya urithi (mRNA na DNA), synthesis ya virusi protini katika maabara, na kuingizwa kwa habari ya urithi wa coronavirus katika virusi vingine zisizo na madhara ambayo ni kisha injected. Matumizi ya mbinu hizi yametokeza chanjo chache sana zenye matokeo na zilizokubaliwa kwa maambukizo yoyote ya virusi hadi sasa. Ripoti za hivi karibuni za ufanisi wa chanjo za Pfizer, BioNTech na Moderna COVID-19, ambazo zote ni chanjo za mRNA, ni za kutia moyo. Ingawa ni kweli kwamba majaribio ya hatua ya wanyama kwa chanjo hizi yalitumia chembe za kiinitete zilizotokana na utoaji mimba, kwa kupendeza, haionekani kwamba mbinu za uzalishaji zilitumia chembe hizo. Uangalifu mkubwa pia unaelekezwa kwenye matumizi ya adenoviruses, kikundi cha virusi vya kawaida vya kupumua. Baada ya kuondoa virusi na kuingiza nyenzo za maumbile ya coronavirus, bidhaa inayotokana inaweza kutumika kwa chanjo. Hata hivyo, kama ilivyo na chanjo nyingine mpya, itifaki ya utoaji wa adenovirus haijazalisha chanjo yenye leseni licha ya majaribio ya miaka mingi. "Kuna wasiwasi zaidi juu ya matumizi ya kawaida ya mstari wa seli za kiinitete zinazotokana na utoaji mimba kutengeneza chanjo hizi na makampuni kama vile AstraZeneca na Johnson & Johnson. """ Kwa kusikitisha, chanjo nyingine nyingi zinazotengenezwa sasa hutumia pia chembe za chembe zinazotokana na watoto waliofukuzwa mimba ili kutokezwa. Kwa bahati nzuri, kuna njia nyingine ambazo hazivunji kanuni hii ya msingi ya maadili na adili. Katika miongo ya hivi karibuni, zaidi ya chanjo 50 za virusi zimekubaliwa kwa kutumia chanjo iliyopunguzwa au isiyofanya kazi. Chanjo nyingi hazikutumiwa katika uzalishaji wa chembe za kiinitete zilizotokana na utoaji-mimba. Virusi hivyo hupandwa katika maabara na kuvunwa, kisha hupunguzwa nguvu au kufutwa kazi ili kutumiwa kama chanjo salama. Kwa kuongezea, njia nyingine za utengenezaji na itifaki za maadili hutumiwa, ikiwa ni pamoja na matumizi ya Taasisi ya Utafiti wa Matibabu ya John Paul II ya kamba ya umbilical na seli za msingi za watu wazima. Hizi na mbinu nyingine za maadili hutoa motisha kwa ajili ya wakati ujao, ambapo hakuna chanjo itakayovunja heshima ya maisha ya kibinadamu katika uzalishaji wao.... "Kama ilivyoelezwa katika taarifa ya shirika la ""American Association of Pro-Life Obstetricians and Gynecologists"" (AAPL) na ""American College of Pediatrics"" (ACPED) na ""Catholic Medical Association"" (CMA) na ""Catholic Medical and Dental Association"" (CMA) na ""CCA"" na ""CCA"" na ""CCA"" na ""CCA"" na ""CCA"" na ""CCA"" na ""CCA"" na ""CCA"" na ""CCA"" na ""CCA"" na ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""CCA ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""C ""